Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
NMTC
NMTC
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
NMTC News
TELO, PCSA, RVPH, NMTC, BRTX Experience After-Hours Trading Surge Amid Limited News and Specific Updates
Oct 07 2025
NASDAQ.COM
Biotech Stocks Recover in After-Hours Trading Driven by Positive Sector Trends
Oct 01 2025
NASDAQ.COM
NeuroOne® Obtains FDA 510(k) Approval for OneRF® Trigeminal Nerve Ablation System to Address Facial Pain
Aug 18 2025
Newsfilter
NeuroOne Medical Technologies Receives FDA Approval for OneRF Trigeminal Nerve Ablation System
Aug 18 2025
NASDAQ.COM
NeuroOne Medical Technologies Third Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag
Aug 16 2025
Yahoo Finance
NeuroOne (NMTC) Q3 2025 Earnings Call Transcript
Aug 14 2025
NASDAQ.COM
NeuroOne Medical Technologies Corporation (NMTC) Q3 2025 Earnings Call Transcript
Aug 14 2025
Newsfilter
NeuroOne® Reports Third Quarter Fiscal Year 2025 Financial Results; Revenue Increases 105% YoY and Gross Margin Expands to 53.9%
Aug 14 2025
Newsfilter
NeuroOne® to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time - Update
Jul 31 2025
Newsfilter
NeuroOne® to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time - Update
Jul 31 2025
Yahoo Finance
NeuroOne® to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time
Jul 31 2025
Newsfilter
NeuroOne Medical Technologies Reports Successful Seizure-Free Milestone in First Patient Treated with OneRF® Ablation System
Jun 23 2025
NASDAQ.COM
NeuroOne Strengthens Leadership Team with Appointment of Emily Johns as General Counsel and Corporate Secretary
Jun 03 2025
Newsfilter
NeuroOne to Attend MedInvest's MedTech, AI & Digital Health Conference on June 3-4, 2025
May 29 2025
Newsfilter
NeuroOne® Reports Second Quarter Fiscal Year 2025 Financial Results; Gross Margin Improves Significantly YoY to 55.6%
May 13 2025
Newsfilter
NeuroOne Appoints Renowned Neurosurgeon Dr. Parag Patil as Chief Medical Advisor
May 12 2025
Newsfilter
Show More News
